US Stock MarketDetailed Quotes
PRME Prime Medicine
- 3.450
- -0.420-10.85%
Close Oct 1 16:00 ET
- 3.420
- -0.030-0.87%
Pre 08:20 ET
414.11MMarket Cap-1589P/E (TTM)
3.925High3.450Low4.88MVolume3.910Open3.870Pre Close17.59MTurnover8.43%Turnover RatioLossP/E (Static)120.03MShares9.86052wk High2.11P/B199.78MFloat Cap3.39052wk Low--Dividend TTM57.91MShs Float21.730Historical High--Div YieldTTM12.27%Amplitude3.390Historical Low3.601Avg Price1Lot Size
Prime Medicine Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -11.44%-45.49M | -62.91%-67.71M | -25.48%-165.41M | -42.82%-43.86M | -30.13%-39.17M | -101.85%-40.82M | 18.18%-41.56M | -286.79%-131.83M | -132.90%-30.71M | -213.33%-30.1M |
| Net income from continuing operations | -30.53%-55.33M | -16.15%-45.76M | -62.64%-198.13M | -67.10%-65.64M | -72.77%-50.71M | -44.42%-42.39M | -65.26%-39.4M | 26.33%-121.82M | 37.56%-39.28M | -78.83%-29.35M |
| Operating gains losses | ---- | ---- | 250.00%28K | ---- | ---- | ---- | ---- | --8K | --0 | ---- |
| Depreciation and amortization | 37.57%1.54M | 25.00%1.32M | 109.22%4.65M | 43.33%1.25M | 95.88%1.24M | 160.00%1.12M | 259.04%1.05M | 291.55%2.22M | 279.91%870K | 277.84%631K |
| Deferred tax | -532.26%-134K | 166.34%134K | 71.06%-279K | --0 | -150.94%-108K | 107.01%31K | 62.03%-202K | -54.49%-964K | -116.25%-202K | 108.95%212K |
| Other non cash items | -357.16%-8.93M | 18.26%3.35M | 30.62%12.79M | 19.66%3.35M | 13.21%3.14M | 41.93%3.47M | 59.49%2.83M | -89.94%9.79M | -96.81%2.8M | 103.79%2.77M |
| Change In working capital | 256.66%8.75M | -249.48%-30.11M | 107.48%2.65M | 1,133.99%14.45M | 162.34%2.4M | -456.70%-5.59M | 74.87%-8.62M | -213.55%-35.4M | -96.29%1.17M | -393.33%-3.85M |
| -Change in prepaid assets | 106.85%275K | -117.43%-2.79M | -444.02%-9.46M | 36.93%-415K | -260.75%-3.74M | -1,098.21%-4.01M | -540.07%-1.29M | -96.38%-1.74M | -170.78%-658K | -171.47%-1.04M |
| -Change in payables and accrued expense | 382.22%10.69M | -424.29%-23.86M | 204.20%24.4M | 304.78%18.29M | 1,625.97%8.44M | -42.46%2.22M | 85.90%-4.55M | -164.34%-23.42M | -86.47%4.52M | -25.46%489K |
| -Change in other current liabilities | 41.66%-2.21M | -24.49%-3.46M | -19.98%-12.3M | -27.40%-3.43M | 30.30%-2.3M | -94.26%-3.79M | -20.49%-2.78M | -136.67%-10.25M | -69.61%-2.69M | -213.09%-3.3M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -11.44%-45.49M | -62.91%-67.71M | -25.48%-165.41M | -42.82%-43.86M | -30.13%-39.17M | -101.85%-40.82M | 18.18%-41.56M | -286.79%-131.83M | -132.90%-30.71M | -213.33%-30.1M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -75.26%6.89M | -192.40%-37.03M | 139.73%18.71M | 401.64%41.29M | -179.55%-37.77M | 154.85%27.86M | -141.00%-12.67M | 36.03%-47.1M | -212.61%-13.69M | -76.94%-13.51M |
| Net PPE purchase and sale | 3.74%-1.9M | -16.26%-2.32M | 45.80%-8.72M | 61.78%-1.84M | 39.28%-2.91M | 58.85%-1.98M | -18.42%-2M | -287.83%-16.1M | -1,160.21%-4.81M | -162.66%-4.79M |
| Net investment purchase and sale | -70.69%8.8M | -225.41%-34.71M | 191.00%27.61M | 586.08%43.13M | -299.78%-34.86M | 166.32%30.01M | -132.82%-10.67M | 56.02%-30.34M | -168.98%-8.87M | -47.30%-8.72M |
| Net other investing changes | ---- | ---- | 74.44%-170K | --0 | --0 | ---- | ---- | -34.07%-665K | 99.69%-1K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -75.26%6.89M | -192.40%-37.03M | 139.73%18.71M | 401.64%41.29M | -179.55%-37.77M | 154.85%27.86M | -141.00%-12.67M | 36.03%-47.1M | -212.61%-13.69M | -76.94%-13.51M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -53.33%35K | 231,263.24%157.33M | -99.64%655K | -99.89%194K | 146.56%318K | 112.02%75K | 105.35%68K | -32.60%181.49M | 17,049.63%184.07M | -68,200.00%-683K |
| Net common stock issuance | --0 | --132.06M | --0 | ---- | ---- | --0 | --0 | --185.32M | ---- | ---- |
| Proceeds from stock option exercised by employees | -53.33%35K | 28,241.18%19.27M | 199.09%655K | 24.36%194K | 404.76%318K | --75K | --68K | --219K | --156K | --63K |
| Net other financing activities | --0 | --6M | ---- | ---- | ---- | ---- | ---- | -272.19%-4.04M | ---1.4M | ---746K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -53.33%35K | 231,263.24%157.33M | -99.64%655K | -99.89%194K | 146.56%318K | 112.02%75K | 105.35%68K | -32.60%181.49M | 17,049.63%184.07M | -68,200.00%-683K |
| Net cash flow | ||||||||||
| Beginning cash position | -26.74%107.66M | -72.62%55.07M | 1.29%201.12M | -6.49%57.46M | 26.80%134.07M | -17.15%146.96M | 1.29%201.12M | 436.97%198.55M | -69.38%61.44M | -51.48%105.74M |
| Current changes in cash | -199.28%-38.56M | 197.10%52.59M | -5,780.51%-146.05M | -101.71%-2.39M | -72.98%-76.62M | 82.01%-12.89M | -155.80%-54.16M | -98.41%2.57M | 6,691.46%139.67M | -156.87%-44.29M |
| End cash Position | -48.46%69.1M | -26.74%107.66M | -72.62%55.07M | -72.62%55.07M | -6.49%57.46M | 26.80%134.07M | -17.15%146.96M | 1.29%201.12M | 1.29%201.12M | -69.38%61.44M |
| Free cash flow | -10.74%-47.39M | -60.77%-70.03M | -17.72%-174.14M | -28.65%-45.7M | -20.60%-42.08M | -71.02%-42.8M | 17.00%-43.56M | -286.91%-147.92M | -161.82%-35.53M | -205.24%-34.89M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data